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IntroductIon
Musculoskeletal extracellular volume- fraction (ECV) 
comprises the fluid- filled space between the cells within the 
tissue (the interstitium) and the blood plasma. It not only 
represents a conduit for solute exchange from the capillary 
to the lymphatic system but also affects cellular behaviour 
and fluid exchange within the tissue.1
T1 weighted imaging post- contrast is useful for identifying 
focal pathology but of limited use for diffuse disease, and 
is inherently qualitative.2 T1 measurement allows a more 
objective assessment, but post- contrast values on their own 
are sensitive to several patient and method related factors 
so there has been widespread interest in other areas (e.g. 
cardiology) in the estimation of ECV from pre- and post- 
contrast T1 measurements.2–6
In cardiac magnetic resonance (MR), ECV measure-
ment of the myocardium by T1- mapping before and after 
gadolinium- based contrast agent (GBCA) administra-
tion is sensitive to focal and diffuse fibrosis, oedema and 
myocyte hypertrophy and is used to study a range of isch-
aemic and non- ischaemic subclinical myocardial patholo-
gies.3–5 ECV mapping has been proven to be sensitive to 
both subtle and global changes in myocardial fibrosis that 
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objective: This study aimed to assess the feasibility of 
extracellular volume- fraction (ECV) measurement, and 
time to achieve contrast equilibrium (CE), in healthy 
muscles, and to determine whether in- flow and partial- 
volume errors in the femoral artery affect measurements, 
and if there are differences in the partition coefficient (λ) 
between muscles.
Methods: T1 was measured in the biceps femoris, vastus 
intermedius, femoral artery and aorta of 10 healthy 
participants. This was repeated alternately between 
the thigh and aorta for ≥25 min following a bolus of 
gadoterate meglumine. λ was calculated for each 
muscle/blood measurement. Time to CE was assessed 
semi- quantitatively.
results: 8/10 participants achieved CE. Time to CE = 
19±2 min (mean ± 95% confidence interval). Measured λ: 
biceps femoris/aorta = 0.210±0.034, vastus intermedius/
aorta = 0.165±0.015, biceps femoris/femoral artery 
= 0.265±0.054, vastus intermedius/femoral artery = 
0.211±0.026. There were significant differences in λ 
between the muscles when using the same vessel (p 
< 0.05), and between λ calculated in the same muscle 
when using different vessels (p < 0.05).
conclusion: ECV measurements in the thigh are clini-
cally feasible. The use of the femoral artery for the blood 
measurement is associated with small but significant 
differences in λ. ECV measurements are sensitive to 
differences between muscles within the healthy thigh.
advances in knowledge: This paper determines the 
time to contrast equilibrium in the healthy thigh and 
describes a method for measuring accurately ECV in 
skeletal muscle. This can aid in the diagnosis and under-
standing of inflammatory auto- immune diseases.
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Recently, it has been shown that ECV measurements in skel-
etal muscle could be important in assessing and understanding 
inflammatory and fibrotic diseases which affect skeletal muscle. 
Banypersad et al7 measured ECV in the biceps, using a cardiac 
MR protocol, where they found a significant (p < 0.0001) increase 
in ECV in patients with amyloidosis compared to healthy volun-
teers across multiple organs and tissues. Similarly, Barison et al8 
measured ECV of the pectoralis and latissimus dorsi (visible on 
cardiac MR) and found a greater ECV for patients with sclero-
derma compared to healthy volunteers (23±6% vs. 18±4%, p < 
0.01). More recently, DeMarchi et al9 have shown that sclero-
derma can be detected in both cardiac and skeletal muscles using 
LGE, and Huber et al10,11 demonstrated that ECV measurements 
in skeletal muscle (again those visible on cardiac MR) offered 
high sensitivity and specificity (95 and 80% respectively – 
receiver operator characteristic (ROC) area under curve (AUC) 
of 0.94) in differentiating patients with idiopathic inflammatory 
myopathy (IIM) and healthy controls and similar levels (sensi-
tivity − 95%, specificity – 89%, ROC AUC – 0.96) at differenti-
ating between IIM and acute viral myocarditis patients.
However, these studies examined skeletal muscle visible at the 
edge of the field of view of a cardiac image, where errors due to 
B1 inhomogeneity could be significant. Furthermore, accurate 
ECV measurement requires T1 measurements pre- contrast 
and after contrast- agent equilibrium (CE) is established (i.e. 
when the exchange of contrast agent between the interstitium 
and the blood pool is such that the concentrations of contrast 
agent in the two volumes are equal). Previous measurements 
have assumed that the time delay necessary to achieve CE in 
skeletal muscle and the heart is the same. However, the lower 
resting perfusion rate of skeletal muscle may lengthen the 
time necessary for equilibrium to be established, and insuf-
ficient waiting times will cause errors in ECV. Therefore, it 
is important to establish whether or not the waiting times of 
around 15–20 min, that are routinely used to ensure CE in 
the heart, are adequate in the muscle, and what magnitude of 
errors in ECV measurements are likely if this order of waiting 
time is used for skeletal muscle. ECV measurements are likely 
to be sensitive to differences in tissue microstructure between 
the quadriceps and hamstrings.12 It is important to establish 
the magnitude of these differences in the normal thigh so that 
differences in future studies in diseased populations can be 
better interpreted.
This study applies ECV measurement in the thigh because 
it provides large, axial muscle volumes for T1 measurement, 
is not affected by cardiac or breathing motion artefacts, and 
the femoral vessels provide relatively large regions for blood 
T1 measurement. However, the blood T1 measurements may 
be susceptible to partial volume effects, as their size may not 
be much larger than the clinically achievable image resolu-
tion. Additionally, inflow effects due to through- plane blood 
flow could compromise accuracy. An alternative approach to 
blood T1 measurement is to measure T1 in the aorta, where 
both partial volume and in- flow effects can be minimized, but 
this lengthens the duration, and adds to the difficulty, of the 
imaging protocol.
The aims of this study were to assess whether ECV measure-
ments in the thigh are clinically feasible, to assess the time to 
CE in the thigh for healthy participants, to determine whether 
in- flow and partial volume errors in the femoral artery affect 
ECV measurements and to determine whether there are differ-
ences in ECV between individual thigh muscles.
MetHodS and MaterIalS
Selection of healthy participants
10 healthy participants (6 females, mean age: 35.0 years., 
range: 24–43 years) were imaged before and after GBCA 
administration between July 2017 and April 2018. Participants 
were recruited under regional ethics committee approval (17/
EM/0079), gave informed written consent to participate in 
the prospective study and were free to withdraw at any time. 
Exclusion criteria were: 4 weeks estimated glomerular filtra-
tion rate <45 ml min−1 1.73 m−2, asthma or chronic obstruc-
tive pulmonary disease, previous anaphylactic reaction to 
GBCAs, contraindications for MRI (claustrophobia, MR 
unsafe implants or foreign bodies, or pregnancy), history of 
rheumatic diseases, or spinal disease with neuropathy.
Imaging
Volunteers were imaged on a Siemens Verio 3 T scanner 
(Siemens Healthcare), feet- first supine with two Siemens small 
4- channel flexible- coils (35 x 17 cm left- right by foot- head) 
placed with the inferior edge approximately 4 cm above the 
patella for the thigh images, and a Siemens body 18 matrix- coil 
placed on the chest for the aorta images. The contralateral leg 
was shielded using an RF blanket. Chest images were acquired 
at an oblique sagittal angle imaging from the top the aortic 
arch following the track of the aorta.
Images were acquired using an inversion recovery steady- state 
free precession sequence. A non- selective inversion pulse was 
used to minimise in- flow effects. An image acquired without an 
inversion pulse [inversion time (TI) = 0 ms] was used to obtain 
the initial estimate for the signal at equilibrium (S0), in fitting the 
monoexponential recovery equation. Imaging parameters are 
given in Table 1.
Contrast [0.1 mmol kg−1 gadoterate meglumine (Dotarem, 
Guerbet LLC)] was administered intravenously as a single 
bolus and then alternate aorta and thigh post- contrast scans 
were then acquired sequentially for at least 25 min. As the 
signal from TI = 0 ms was only used as an initial guess for the 
S0 in the fitting equation, and not used as a data point, it was 
excluded from the post- contrast scans to increase the temporal 
resolution of the data, but included pre- contrast to increase 
the speed and accuracy of the T1- fitting.
The pre- contrast TR for each sequence was set to 10 s so as to 
be greater than five times the maximum T1 for the expected 
biological range. The post- contrast TR was shortened to 6 s to 
reflect the reduction in T1 from the GBCA- administration and 
to decrease the time delay between acquisitions. TIs were also 
shortened post- contrast to reflect the increased rate of recovery. 
The mean time between the start of the two sequences was 73 s.
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Data analysis
Measurement of T1 in-vivo
Image analysis was performed using MATLAB (MATLAB 
R2015a, The MathWorks Inc. Natick, MA, 2015) and ImageJ 
(ImageJ 1.51k, Rasband, W.S., ImageJ, U. S. National Institutes 
of Health, Bethesda, MD, https:// imagej. nih. gov/ ij/, 1997–2018).
Regions of interest (ROIs) were contoured within the muscles 
avoiding muscle fascia. For the femoral artery, a small circular 
ROI was created around a user- defined centre, set within the 
vessel, ensuring that the ROI fell fully within the vessel to mini-
mise partial volume effects (Figure  1a). In the aorta, a rectan-
gular ROI was created around a central line drawn by the user. 
The width was chosen to avoid inclusion of the vessel wall and 
was long enough to span the extent of at least three vertebrae. 
The ROI was located towards the inferior end of the aorta to 
minimise in- flow effects (Figure 1b). All ROIs were drawn using 
ImageJ. ROIs were copied across all images manually adjusting 
for any movement between images.
T1 values for each ROI were obtained by fitting the mean signal 
within the ROIs at the different TIs to a monoexponential 
recovery equation: -
 













Where θ is the inversion angle, to the mean signal intensities 
from each ROI at each time point using a non- linear least squares 
fitting algorithm (lsqcurvefit, MATLAB R2015a). S0, θ, and T1 
are all free parameters in the fit. Constraints were applied so that 
S0 and T1 were positive, and θ was between 0 and π radians.
The signal output of the scanner was not phase corrected from the 
inversion recovery, and so only the magnitude of the signal data 
was obtained. To fit the magnitude data to the monoexponential 
recovery equation the method of Messroghli et al13 was used. The 
sign of the signal from each TI point, starting with the lowest 
TI, was changed sequentially from positive to negative, keeping 
previously changed values negative, and the fitting algorithm was 
run for each combination. The coefficient of determination (R2) 
for each fit was recorded and the fit with the maximum R2 value 
was chosen. Data points with values below 10% of the maximum 
signal in the sequence were considered to be influenced by the 
Rician noise floor and were therefore excluded from the fitting.
Determining the partition coefficient and time to 
contrast equilibrium


















To ensure that that blood and muscle values from the same 
time point were used, blood ΔR1 values were temporally inter-
polated using a biexponential decay model to reflect the more 
rapid decay from the GBCA entering the extravascular space 
and the slower decay from renal extraction.14 This allowed a 
Table 1. Pre- and post- contrast acquisition parameters for the thigh and aorta sequences
Parameter Pre- contrast values Post- contrast values
TR (ms) 1000 6000
TE (ms) 1.83 1.83
TI (ms) 0, 80, 120, 160, 640, 3550, 5100 80, 120, 160, 320, 640, 2550
Flip angle (o) 60 60
Slice thickness (mm) 5 5
Bandwith (Hz/px) 930 930
FoV – Leg (mm x mm) 250 × 250 250 × 250
FoV – Aorta (mm x mm) 300 × 300 300 × 300
Matrix size 256 × 256 256 × 256
FOV, field of view; TE, echo time; TI, inversion time; TR, repetition time.
Contrast [0.1 mmol kg−1 gadoterate meglumine (Dotarem, Guerbet LLC)] was administered intravenously as a single bolus.
Figure 1. (a) Example ROIs on for vastus intermedius, biceps 
femoris, and femoral artery on the thigh images. (b) Example 
ROI on for aorta on the chest images. ROI, region of interest.
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more physiologically appropriate interpolation of the blood ΔR1 
values than linear interpolation.
As GBCAs distribute themselves only within extracellular space 
in the interstitium and the blood–plasma within the vasculature, 
then at equilibrium the ratio of the GBCA concentrations will be 
equal to the ratio of ECV fractions (assuming sufficiently rapid 
water exchange) so that the effect of the contrast agent can be 
assumed to be averaged over the whole tissue volume. The ECV 
fraction in the blood is the plasma volume fraction, equal to 
1- haematocrit (1 - hct), and so the ECV fraction in the muscle 
can be calculated (below) if the haematocrit is known, or esti-
mated using an assumed value (e.g. 0.42 haematocrit as found by 
Jacob et al.)15





λ was then plotted against time since contrast administration 
and a third- order polynomial was fitted to smooth the data. 
Example figures of the biexponential and third- order polynomial 
fits are shown for one volunteer who did not reach equilibrium 
(Figure 2a–c) and for one who did (Figure 3a–c).
Time to CE was defined as the next acquired scan time point 
after the gradient of the polynomial reached zero. To investigate 
the magnitude of errors in ECV if the post- contrast imaging 
was limited to a clinically feasible time frame a pragmatic post- 
contrast delay time of 20 min16 was chosen.
Statistical analysis
All statistical analysis was performed in MATLAB. Comparisons 
between groups were performed using a Wilcoxon signed- rank 
test (significance at p < 0.05). All results are reported as mean 






 . No volunteers were 
excluded.
reSultS
Measurement of T1 in-vivo
There was no significant difference between the native T1 values 
of blood in the aorta compared to the femoral artery (aorta 1808 
± 166 ms, femoral artery 1873 ± 298 ms; p = 0.70), but there was 
a significant difference between the T1 values of the two muscles 
(biceps femoris 1352 ± 21 ms, vastus intermedius 1387 ± 42 ms; 
p < 0.005) (Figure 4).
Determining the partition coefficient and time to 
contrast equilibrium
A CE plateau was achieved in 8/10 healthy participants. There 
was no significant difference between the times to CE for the 
two muscles (p = 0.3) or between measurements made using the 
aorta or femoral artery for the blood values (p = 1.0) (Table 2 and 
Figure 5a).
Partition coefficient (λ) measurements at equilibrium (Table  2 
and Figure  5b) were significantly higher in the biceps femoris 
compared to the vastus intermedius, regardless of which vessel 
was used (aorta: p = 0.03, femoral artery: p = 0.02). λ is also 
higher when using the femoral artery for blood ΔR1 values, 
regardless of the muscle used (biceps femoris: p = 0.01, vastus 
intermedius: p = 0.01).
Comparisons between λ values measured using the values at 
20 min (Figure 5c) and the value at equilibrium (or the end time 
point of the experiment for participants who didn’t reach CE) are 
given in Table 2. Differences in λ (Δλ) between equilibrium and 
Figure 2. For a volunteer who did not reach equilibrium: (a) 
measured change in relaxation rate of blood measured in the 
aorta and femoral artery, with biexponential fits. (b) Partition 
coefficient in the Biceps Femoris against time graphs for aorta 
and femoral artery, with third- order polynomial fit. (c) Parti-
tion coefficient in the Vastus Intermedius against time graphs 
for aorta and femoral artery, with third- order polynomial fit. 
Coefficient of determination (R2) for fit is given in brackets.
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20 min (Figure 5d) were small (0.002–0.004) and not significant 
(p = 0.16–0.94) for all muscle vessel combinations.
dIScuSSIon
This study has shown that ECV measurements are feasible in 
thigh muscle and that they are sensitive to differences between 
muscles. In most cases, CE was achieved in a clinically practicable 
time frame of 20 min. There were small but significant changes 
in λ between the femoral artery and aorta- based blood ΔR1 
measurements.
Measured pre- contrast T1 measurements were comparable 
to the literature.17–21 The observed difference in pre- contrast 
T1 measurements between the biceps femoris and the vastus 
intermedius is consistent with known differences in muscle 
fibre populations and fat- fractions between quadriceps and 
hamstrings.22–25 In general, T1 measurements in blood had a 
larger standard deviation than those in muscle, which could be 
due to flow effects, variability in haematocrit, or blood oxygen-
ation levels.26–28
In most cases, the time to CE was achieved in <24 min. For those 
cases, if a pragmatic cut- off time of 20 min had been used, the 
resulting error in the estimated ECV would be less than 1% 
(assuming 0.42 haematocrit).15,29 This suggests that skeletal- 
muscle ECV measurements would be achievable within a clin-
ically relevant time scale with very small errors due to poor 
contrast equilibrium. However, 2/10 healthy participants did 
not reach CE within the time frame of the experiment. In these 
cases, the mean difference between λ measured at the end of the 
study and that measured after 20 min would lead to an underes-
timation of the ECV approximately equal to 1% for both biceps 
femoris and vastus intermedius across both blood measure-
ments Such errors are unlikely to obscure clinical differences in 
ECV7–11 (which are of the order of 5%). Therefore, we recom-
mend a pragmatic post- contrast imaging time of 20 min. The 
reason for longer CE times compared to cardiac studies may be 
due to lower perfusion in the muscle, and so it takes longer for 
the relative concentrations of contrast in the blood and muscle to 
reach equilibrium. It may be advisable to require some exercise 
prior to skeletal muscle ECV measurements to ensure sufficiently 
high flow rates. This should be addressed in further work.
There was a significant, and systematic, difference in λ at 20 min 
using blood measurements taken from the aorta compared to the 
femoral artery, which may be due to inflow or partial volume 
Figure 3. For a volunteer who did reach equilibrium: (a) meas-
ured change in relaxation rate of blood measured in the aorta 
and femoral artery, with biexponential. (b) Partition coeffi-
cient in the Biceps Femoris against time graphs for aorta and 
femoral artery, with third order polynomial fit. (c) Partition 
coefficient in the Vastus Intermedius against time graphs for 
aorta and femoral artery, with third order polynomial fit. Coef-
ficient of determination (R2) for fit is given in brackets.
Figure 4. Pre- contrast T1s for the four ROIs. There is a signifi-
cant difference between the T1 of the biceps femoris and the 
vastus intermedius (**p < 0.01) but not the two vessels. ROI, 
region of interest.
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effects. The mean difference in λ between both muscles using the 
femoral artery compared to the aorta would cause an approxi-
mate difference in the measured ECV of 2.0±1.7%. This is again 
too small to obscure clinical differences but may justify prefer-
ring the aorta for blood measurements.
The difference in λ for the biceps femoris and vastus interme-
dius could be due to different proportions of type-1 and type-2 
fibres between these muscles. Vincensini et al30 found a higher 
ECV in muscles with higher type-1 fibre percentage (in rabbits) 
and as the hamstrings have more type-1 fibres than the quadri-
ceps24,25 this could explain the greater λ in the biceps femoris 
observed in this study. This is consistent with other studies22–25 
where differences in diffusion and fat fraction have also been 
noted. Estimated ECVs for the two muscle populations (aorta/
femoral artery: biceps femoris – 9 ± 2 %/12±4%; vastus interme-
dius – 7 ± 1 % / 9±1%) are consistent with ECV measurements in 
skeletal muscle in the literature (10 ± 2% - Huber et al10,11 and 
9% - Banypersad et al).7
We acknowledge a number of limitations in this study, including 
small sample size. The use of magnitude images incorporates 
small errors in T1, and this could have been improved by using 
a phase- sensitive recovery sequence. Although respiratory and 
Table 2. Mean time to CE, and partition- coefficients measured at three different time points (at equilibrium, if reached, at approx-
imately 20 min, and at the end of the scanning session) for all muscle vessel pairs
Muscle Biceps femoris Vastus Intermedius
Vessel Aorta Femoral artery Aorta Femoral artery
Time to CE (min) 19.2 ± 6.1 20.4 ± 3.9 19.1 ± 4.9 18.9 ± 5.0
λ at Equilibrium 0.210 ± 0.034 0.265 ± 0.054 0.165 ± 0.015 0.211 ± 0.026
λ at 20 min 0.212 ± 0.027 0.262 ± 0.045 0.174 ± 0.016 0.213 ± 0.023
λ at End 0.225 ± 0.030 0.273 ± 0.042 0.182 ± 0.019 0.219 ± 0.021
Δλ: 20 min – Equilibrium (n = 8) −0.002 ± 0.005 −0.002 ± 0.005 0.004 ± 0.005 0.003 ± 0.007
Δλ: End - 20 min (n = 2) 0.032 0.032 0.024 0.023
CE, contrast equilibrium.
The reported difference in partition coefficient (Δλ) is the difference between λ at 20 min and at equilibrium if reached, and at the end of the time- 
course if not.
Figure 5. (a) Time to contrast equilibrium for all muscle/vessel combinations. There was no significant difference in CE values 
between any muscle/vessel combinations. (b) Partition coefficient values for the volunteers who reached equilibrium for all mus-
cle/vessel combinations (*p < 0.05, **p < 0.01). (c) Partition coefficient values for all volunteers at approximately 20 min (***p < 
0.005). (d) The difference in the measured partition coefficient at 20 min for the volunteers who reached equilibrium compared to 
the equilibrium value. There was no significant difference between the value at 20 min and that at equilibrium.
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cardiac motion artefacts did not affect the region of the aorta 
where measurements were taken, gating techniques could have 
improved the quality of the data. A longer imaging time would 
have ensured that equilibrium was reached but could have 
reduced compliance and lead to discomfort and gross motion 
artefacts. The thigh images were not fat- suppressed which could 
have caused a biexponential T1 recovery due to the different T1 
values of fat and water. To estimate the impact of fat on our ECV 
measurements fitting was repeated using a biexponential equa-
tion with an assumed fat T1 of 370 ms16 and a fat- fraction of 5% 
in the vastus intermedius and 10%31 in the biceps femoris. There 
was a small but significant difference in ECV at equilibrium 
(<1%, p < 0.05), and in the time to CE (3 min, p < 0.05). Errors 
of this magnitude would not be sufficient to alter the conclusions 
of this study.
concluSIon
ECV measurements in the thigh are clinically feasible and most 
healthy participants would reach CE using a post- contrast delay 
of 20 min. In cases where CE time is uncharacteristically long, 
using such a 20 min delay time would not induce ECV errors 
greater than 4%. There are small errors in partition coefficient 
associated with using the femoral artery for blood- pool measure-
ments, so aortic blood- pool measurements are recommended 
wherever possible. There are significant differences in partition 
coefficient between the biceps femoris and vastus intermedius, 
which are consistent with known differences in muscle fibre 
populations.
acknowledGeMent
We acknowledge the work of the radiographers Brian Chaka and 
Dominic Bertham, and of Bilkis Begum who helped cannulate 
and prepare volunteers for MRI. The research is supported by 
the National Institute for Health Research (NIHR) infrastructure 
at Leeds. The views expressed are those of the authors and not 
necessarily those of the NHS, the NIHR or the Department of 
Health.
conFlIct oF IntereSt
The authors of this manuscript declare no relationships with any 
companies, whose products or services may be related to the 
subject matter of the article.
reFerenceS
 1. Scallan J, Huxley VH, Korthuis RJ. Capillary 
Fluid Exchange: Regulation, Functions, and 
Pathology. In: Capillary Fluid Exchange: 
Regulation, Functions, and Pathology. 2. 
San Rafael (CA: Morgan & Claypool Life 
Sciences; 2010 01. 1–94. https://www. ncbi. 
nlm. nih. gov/ books/ NBK53446/.. doi: https:// 
doi. org/ 10. 4199/ C000 06ED 1V01 Y201 002I 
SP003
 2. Schelbert EB, Messroghli DR. State of the art: 
clinical applications of cardiac T1 mapping. 
Radiology 2016; 278: 658–76. doi: https:// doi. 
org/ 10. 1148/ radiol. 2016141802
 3. Kellman P, Wilson JR, Xue H, Bandettini 
WP, Shanbhag SM, Druey KM, et al. 
Extracellular volume fraction mapping 
in the myocardium, part 2: initial clinical 
experience. J Cardiovasc Magn Reson 2012; 
14: 64. doi: https:// doi. org/ 10. 1186/ 1532- 
429X- 14- 64
 4. Ugander M, Oki AJ, Hsu L- Y, Kellman P, 
Greiser A, Aletras AH, et al. Extracellular 
volume imaging by magnetic resonance 
imaging provides insights into overt and 
sub- clinical myocardial pathology. Eur Heart 
J 2012; 33: 1268–78. doi: https:// doi. org/ 10. 
1093/ eurheartj/ ehr481
 5. Haaf P, Garg P, Messroghli DR, Broadbent 
DA, Greenwood JP, Plein S. Cardiac T1 
mapping and extracellular volume (ECV) 
in clinical practice: a comprehensive review. 
J Cardiovasc Magn Reson 2016; 18: 89. doi: 
https:// doi. org/ 10. 1186/ s12968- 016- 0308-4
 6. Perea RJ, Ortiz- Perez JT, Sole M, Cibeira 
MT, de Caralt TM, Prat- Gonzalez S, et al. 
T1 mapping: characterisation of myocardial 
interstitial space. Insights Imaging 2015; 
6: 189–202. doi: https:// doi. org/ 10. 1007/ 
s13244- 014- 0366-9
 7. Banypersad SM, Bandula S, Sado D, Pinney 
JH, Gibbs SD, Maestrini V, et al. Multiorgan 
ECV as measured by EQ- MRI in systemic 
amyloidosis. J Cardiovasc Magn Reson 2013; 
15(Suppl 1): O34 doi: https:// doi. org/ 10. 
1186/ 1532- 429X- 15- S1- O34
 8. Barison A, Aquaro GD, Pugliese NR, 
Cappelli F, Chiappino S, Vergaro G, et al. 
Measurement of myocardial amyloid 
deposition in systemic amyloidosis: insights 
from cardiovascular magnetic resonance 
imaging. J Intern Med 2015; 277: 605–14. doi: 
https:// doi. org/ 10. 1111/ joim. 12324
 9. Barison A, Gargani L, De Marchi D, Aquaro 
GD, Guiducci S, Picano E, et al. Early 
myocardial and skeletal muscle interstitial 
remodelling in systemic sclerosis: insights 
from extracellular volume quantification 
using cardiovascular magnetic resonance. 
Eur Heart J Cardiovasc Imaging 2015; 16: 
74–80. doi: https:// doi. org/ 10. 1093/ ehjci/ 
jeu167
 10. Huber AT, Lamy J, Bravetti M, et al. 
Comparison of Mr T1 and T2 mapping 
parameters to characterize myocardial and 
skeletal muscle involvement in systemic 
idiopathic inflammatory myopathy (IIM. Eur 
Radiol 2019;: 1–9.
 11. Huber AT, Bravetti M, Lamy J, Bacoyannis 
T, Roux C, de Cesare A, et al. Non- Invasive 
differentiation of idiopathic inflammatory 
myopathy with cardiac involvement from 
acute viral myocarditis using cardiovascular 
magnetic resonance imaging T1 and T2 
mapping. J Cardiovasc Magn Reson 2018; 20: 
1–11. doi: https:// doi. org/ 10. 1186/ s12968- 
018- 0430-6
 12. Farrow M, Grainger AJ, Tan AL, Buch MH, 
Emery P, Ridgway JP, et al. Normal values 
and test- retest variability of stimulated- echo 
diffusion tensor imaging and fat fraction 
measurements in the muscle. Br J Radiol 
2019; 92: 20190143. doi: https:// doi. org/ 10. 
1259/ bjr. 20190143
 13. Messroghli DR, Radjenovic A, Kozerke S, 
Higgins DM, Sivananthan MU, Ridgway JP. 
Modified Look- Locker inversion recovery 
(MOLLI) for high- resolution T1 mapping of 
the heart. Magn Reson Med 2004; 52: 141–6. 
doi: https:// doi. org/ 10. 1002/ mrm. 20110
 14. Weinmann HJ, Brasch RC, Press WR, 
Wesbey GE, Websey GE. Characteristics 
of gadolinium- DTPA complex: a potential 
NMR contrast agent. AJR Am J Roentgenol 
1984; 142: 619–24. doi: https:// doi. org/ 10. 
2214/ ajr. 142. 3. 619
 15. Jacob M, Annaheim S, Boutellier U, Hinske 
C, Rehm M, Breymann C, et al. Haematocrit 
is invalid for estimating red cell volume: a 
prospective study in male volunteers. Blood 
Transfus 2012; 10: 471–9. doi: https:// doi. org/ 
10. 2450/ 2012. 0111- 11
8 of 8 birpublications.org/bjr Br J Radiol;93:20190931
BJR  Goodall et al
 16. Messroghli DR, Moon JC, Ferreira VM, 
Grosse- Wortmann L, He T, Kellman P, et al. 
Clinical recommendations for cardiovascular 
magnetic resonance mapping of T1, T2, 
T2* and extracellular volume: a consensus 
statement by the Society for cardiovascular 
magnetic resonance (SCMR) endorsed by 
the European association for cardiovascular 
imaging (EACVI. J Cardiovasc Magn Reson 
2017; 19Vol. doi: https:// doi. org/ 10. 1186/ 
s12968- 017- 0389-8
 17. Gold GE, Han E, Stainsby J, Wright G, 
Brittain J, Beaulieu C. Musculoskeletal MRI 
at 3.0 T: relaxation times and image contrast. 
American Journal of Roentgenology 2004; 
183: 343–51. doi: https:// doi. org/ 10. 2214/ ajr. 
183. 2. 1830343
 18. Sibley CT, Huang J, Ugander M, Oki A, Han 
J, Nacif MS, et al. Myocardial and blood T1 
quantification in normal volunteers at 3T. J 
Cardiovasc Magn Reson 2011; 13(Suppl 1): 
P51. doi: https:// doi. org/ 10. 1186/ 1532- 429X- 
13- S1- P51
 19. Stanisz GJ, Odrobina EE, Pun J, Escaravage 
M, Graham SJ, Bronskill MJ, et al. T1, T2 
relaxation and magnetization transfer in 
tissue at 3T. Magn Reson Med 2005; 54: 
507–12. doi: https:// doi. org/ 10. 1002/ mrm. 
20605
 20. Morrow JM, Sinclair CDJ, Fischmann A, 
Reilly MM, Hanna MG, Yousry TA, et al. 
Reproducibility, and age, body- weight and 
gender dependency of candidate skeletal 
muscle MRI outcome measures in healthy 
volunteers. Eur Radiol 2014; 24: 1610–20. 
doi: https:// doi. org/ 10. 1007/ s00330- 014- 
3145-6
 21. Zhang X, Petersen ET, Ghariq E, De Vis 
JB, Webb AG, Teeuwisse WM, et al. In vivo 
blood T(1) measurements at 1.5 T, 3 T, and 
7 T. Magn Reson Med 2013; 70: 1082–6. doi: 
https:// doi. org/ 10. 1002/ mrm. 24550
 22. Li K, Dortch RD, Welch EB, Bryant ND, 
Buck AKW, Towse TF, et al. Multi- parametric 
MRI characterization of healthy human thigh 
muscles at 3.0 T - relaxation, magnetization 
transfer, fat/water, and diffusion tensor 
imaging. NMR Biomed 2014; 27: 1070–84. 
doi: https:// doi. org/ 10. 1002/ nbm. 3159
 23. Scheel M, von Roth P, Winkler T, Arampatzis 
A, Prokscha T, Hamm B, et al. Fiber type 
characterization in skeletal muscle by 
diffusion tensor imaging. NMR Biomed 2013; 
26: 1220–4. doi: https:// doi. org/ 10. 1002/ 
nbm. 2938
 24. Polgar J, Johnson MA, Weightman D, 
Appleton D. Data on fibre size in thirty- six 
human muscles. An autopsy study. J Neurol 
Sci 1973; 19: 307–18. doi: https:// doi. org/ 10. 
1016/ 0022- 510x( 73) 90094-4
 25. Edgerton VR, Smith JL, Simpson DR. Muscle 
fibre type populations of human leg muscles. 
Histochem J 1975; 7: 259–66. doi: https:// doi. 
org/ 10. 1007/ BF01003594
 26. Brooks RA, Di Chiro G. Magnetic resonance 
imaging of stationary blood: a review. Med 
Phys 1987; 14: 903–13. doi: https:// doi. org/ 
10. 1118/ 1. 595994
 27. Lu H, Clingman C, Golay X, van Zijl PCM. 
Determining the longitudinal relaxation time 
(T1) of blood at 3.0 Tesla. Magn Reson Med 
2004; 52: 679–82. doi: https:// doi. org/ 10. 
1002/ mrm. 20178
 28. Wu W- C, Jain V, Li C, Giannetta M, Hurt H, 
Wehrli FW, et al. In vivo venous blood T1 
measurement using inversion recovery true- 
FISP in children and adults. Magn Reson Med 
2010; 64: 1140–7. doi: https:// doi. org/ 10. 
1002/ mrm. 22484
 29. Sourbron SP, Buckley DL. Tracer kinetic 
modelling in MRI: estimating perfusion and 
capillary permeability. Phys Med Biol 2012; 
57: R1–33. doi: https:// doi. org/ 10. 1088/ 0031- 
9155/ 57/ 2/ R1
 30. Vincensini D, Dedieu V, Renou JP, Otal 
P, Joffre F. Measurements of extracellular 
volume fraction and capillary permeability 
in tissues using dynamic spin- lattice 
relaxometry: studies in rabbit muscles. 
Magn Reson Imaging 2003; 21: 85–93. doi: 
https:// doi. org/ 10. 1016/ S0730- 725X( 02) 
00638-0
 31. Kumar D, Karampinos DC, MacLeod TD, 
Lin W, Nardo L, Li X, Majumdar S, Souza 
RB, et al. Quadriceps intramuscular fat 
fraction rather than muscle size is associated 
with knee osteoarthritis. Osteoarthritis 
Cartilage 2014; 22: 226–34. doi: https:// doi. 
org/ 10. 1016/ j. joca. 2013. 12. 005
